Page last updated: 2024-10-24

cefuroxime and Anemia, Aplastic

cefuroxime has been researched along with Anemia, Aplastic in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.

Research Excerpts

ExcerptRelevanceReference
"The most common type of infection was pneumonia (48% alone; 72% with other sites involved), which accounted for a high fatality rate (15%); the highest rate occurred during septicemia with pneumonia (50%)."2.65Empiric therapy of infections in hematologic malignancies: a prospective, randomized trial. ( Benini, F; Caramaschi, G; Cetto, GL; Perona, G; Todeschini, G; Vinante, F, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cetto, GL1
Todeschini, G1
Caramaschi, G1
Vinante, F1
Benini, F1
Perona, G1

Trials

1 trial available for cefuroxime and Anemia, Aplastic

ArticleYear
Empiric therapy of infections in hematologic malignancies: a prospective, randomized trial.
    Tumori, 1983, Apr-30, Volume: 69, Issue:2

    Topics: Adolescent; Adult; Aged; Ampicillin; Anemia, Aplastic; Carbenicillin; Cefuroxime; Female; Humans; In

1983